A Study of MF101 in Postmenopausal Women
NCT00906308
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
1200
Enrollment
INDUSTRY
Sponsor class
Conditions
Hot Flushes
Vasomotor Symptoms
Interventions
DRUG:
MF101 5 g/day
DRUG:
Placebo
DRUG:
MF101 10 g/day
Sponsor
Bionovo